This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Disorders of lacrimal system and orbit in diseases classified elsewhere
H7_LACRIMALORBITINOTH
eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1023 |
4. Check minimum number of eventsNone |
1023 |
5. Include endpointsNone |
1023 |
6. Filter based on genotype QC (FinnGen only) |
936 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of lacrimal system and orbit in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Disorders of orbit
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 936 | 767 | 169 |
| Unadjusted period prevalence (%) | 0.24 | 0.27 | 0.08 |
| Median age at first event (years) | 52.74 | 52.39 | 54.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 978
- Matched controls
- 9780
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
104
Kela drug reimbursment
Thyroid insufficiency
14.6
307.7
387
420
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
455.1
307.7
839
128
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
93.9
307.7
516
115
BAA60
NOMESCO Finland
Total thyroidectomy
44.1
307.7
348
121
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
41.2
307.7
275
92
H03BB01
ATC
carbimazole; oral
179.7
307.7
773
201
H03AA01
ATC
levothyroxine sodium; systemic
20.3
307.7
806
1835
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
307.7
856
*
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
172.8
298.6
147
10
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
48.7
263.8
156
38
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
40.7
250.4
155
45
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
+∞
250.0
229
*
H062, E050,
ICD-10 Finland
+∞
236.3
217
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
85.6
188.7
100
13
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
7.7
179.3
767
3149
H50.2
ICD-10 Finland
Vertical strabismus
53.1
166.8
96
20
H53.2
ICD-10 Finland
Diplopia
14.1
161.7
158
132
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.0
133.8
620
2515
H04.10
ICD-10 Finland
Dry eye syndrome
6.8
121.8
220
398
C07AA05
ATC
propranolol; systemic
4.5
114.1
430
1455
H02.3
ICD-10 Finland
Blepharochalasis
28.1
106.7
73
28
H05.2
ICD-10 Finland
Exophthalmic conditions
+∞
106.2
100
*
XCK00
NOMESCO Finland
Perimetry
7.7
105.9
163
247
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.7
102.8
224
481
T85
ICPC
Hyperthyroidism/thyrotoxicosis
23.2
85.8
63
29
E03.89
ICD-10 Finland
Other specified hypothyroidism
6.8
79.0
133
220
T86
ICPC
Hypothyroidism/myxoedema
5.8
69.1
138
269
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.7
68.5
282
967
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
67.5
294
1045
H02AB06
ATC
prednisolone; systemic
3.2
66.5
627
3501
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
11.0
64.8
71
69
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
13.8
63.6
60
46
H50.0
ICD-10 Finland
Convergent concomitant strabismus
21.4
59.5
45
22
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.1
59.5
137
302
ZX120
NOMESCO Finland
Intravenous
4.1
56.2
178
504
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
+∞
54.7
52
*
H02.4
ICD-10 Finland
Ptosis of eyelid
19.9
53.9
42
22
CA1AD
NOMESCO Finland
Orbita CT
137.1
49.3
52
*
ZXA10
NOMESCO Finland
Bilateral
3.1
48.7
256
999
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
48.3
46
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
8.1
44.2
61
80
CEC00
NOMESCO Finland
Recession of extraocular muscle
73.5
43.4
49
7
E03
ICD-10 Finland
Other hypothyroidism
3.8
40.4
135
393
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
11.5
40.0
42
38
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
+∞
39.9
38
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
8.6
38.4
50
61
H50.8
ICD-10 Finland
Other specified strabismus
131.6
35.9
38
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
35.3
281
1335
CAC44
NOMESCO Finland
Combined decompression of orbit
359.6
35.2
35
*
L04AX03
ATC
methotrexate; systemic
3.1
32.4
156
569
A02BC02
ATC
pantoprazole; systemic
2.5
31.8
760
5685
C07AB07
ATC
bisoprolol; oral
2.2
31.8
513
3266
CAC20
NOMESCO Finland
Lateral decompression of orbit
+∞
31.4
30
*
L04AA06
ATC
mycophenolic acid; systemic
8.5
31.4
41
50
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
+∞
30.4
29
*
WF099
NOMESCO Finland
Other radiotherapy
33.8
30.2
39
12
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.4
28.9
75
180
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
154.6
28.8
30
*
XCK10
NOMESCO Finland
Photography of fundus of eye
3.3
28.7
120
401
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
37.3
28.5
36
10
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.8
27.7
64
140
H57.1
ICD-10 Finland
Ocular pain
4.5
27.2
69
163
H02AB07
ATC
prednisone; oral
2.6
26.9
186
816
CS494
NOMESCO Finland
Other visual field testing
5.4
26.0
52
100
A11CC03
ATC
alfacalcidol; systemic
6.4
25.5
43
70
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
23.8
289
1607
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.9
23.7
123
464
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
128.2
23.7
25
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
5.0
23.1
51
107
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
22.1
389
2460
Z3231
NOMESCO Finland
Registered nurse
2.0
21.7
296
1710
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
224.8
21.7
22
*
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
32.0
21.6
28
9
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.2
21.4
58
144
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
21.3
403
2603
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
17.0
21.1
33
20
H01.0
ICD-10 Finland
Blepharitis
3.3
21.0
85
278
CEW99
NOMESCO Finland
Other operation on extraocular muscle
78.6
20.8
23
*
E05.5
ICD-10 Finland
Thyroid crisis or storm
214.4
20.7
21
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.2
20.6
88
297
2AB04, ,
NOMESCO Finland
27.7
20.1
27
10
WX402
NOMESCO Finland
General anaesthesia
2.0
20.0
266
1515
N05CF01
ATC
zopiclone; oral
1.9
20.0
353
2218
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
36.6
19.9
25
7
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
+∞
19.9
19
*
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
19.9
19
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
18.6
19.2
29
16
CBB21
NOMESCO Finland
Correction of lax skin and resection of herniated fat in upper eyelid
+∞
18.8
18
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.9
18.7
329
2055
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
102.0
18.6
20
*
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
193.6
18.6
19
*
E05.89
ICD-10 Finland
Other thyrotoxicosis
33.6
18.0
23
7
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.0
17.5
82
292
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
17.1
463
3279
S01GX01
ATC
cromoglicic acid; ophthalmic
2.0
16.8
239
1385
WF002
NOMESCO Finland
Radical radiotherapy
3.4
16.7
60
182
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
172.8
16.5
17
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
12.4
16.4
29
24
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
21.4
16.0
23
11
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.9
15.5
34
71
F29
ICPC
Eye symptom/complaint other
2.3
15.3
123
571
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
20.4
15.1
22
11
S01KA02
ATC
hypromellose; ophthalmic
5.2
15.1
31
61
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
15.0
166
875
H02AB09
ATC
hydrocortisone; systemic
4.3
14.4
37
88
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
14.3
86
349
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
10.6
14.3
27
26
CE2W4
NOMESCO Finland
Eye movement mapping
43.2
14.1
17
*
XCH00
NOMESCO Finland
Eye pressure measurement
3.2
13.7
55
179
H40.0
ICD-10 Finland
Glaucoma suspect
2.4
12.9
89
385
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
70.8
12.6
14
*
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
+∞
12.5
12
*
WX002
NOMESCO Finland
Sedation and analgesia
1.9
12.5
189
1107
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
13.4
12.5
21
16
106
Kela drug reimbursment
Hypoparathyroidism
16.1
12.2
19
12
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.9
12.1
36
96
H02.8
ICD-10 Finland
Other specified disorders of eyelid
27.1
12.1
16
6
CA1BD
NOMESCO Finland
Extensive orbita CT
65.8
11.6
13
*
1XC02, ,
NOMESCO Finland
10.2
11.5
22
22
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
11.5
11
*
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
8.5
11.3
24
29
H03BA02
ATC
propylthiouracil; oral
25.3
11.2
15
6
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
43.8
10.9
13
*
N07BA03
ATC
varenicline; oral
2.6
10.7
62
247
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
10.7
215
1366
Z2221
NOMESCO Finland
Medical doctor
1.6
10.5
274
1867
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
+∞
10.4
10
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
10.7
10.3
19
18
S01XA18
ATC
ciclosporin; ophthalmic
19.0
10.3
15
8
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.7
10.2
32
89
ZXE00
NOMESCO Finland
One hour or less
1.6
10.1
369
2721
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
14.8
10.0
16
11
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.0
9.8
118
638
H50.52
ICD-10 Finland
Exophoria
4.8
9.8
22
47
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
9.7
9.8
19
20
CD2S4
NOMESCO Finland
Photography of eye
13.5
9.7
16
12
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.5
9.6
20
24
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.2
9.5
37
118
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
30.3
9.4
12
*
H02.2
ICD-10 Finland
Lagophthalmos
+∞
9.4
9
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
13.8
9.2
15
11
WX892
NOMESCO Finland
Monitored bed care
2.3
9.2
70
317
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.2
8.8
74
350
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.1
8.7
83
412
F01
ICPC
Eye pain
3.0
8.7
37
125
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
4.0
8.6
24
61
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.2
8.6
73
347
ZXA00
NOMESCO Finland
Right side
1.6
8.5
233
1596
H02.1
ICD-10 Finland
Ectropion of eyelid
90.8
8.4
9
*
CBD99
NOMESCO Finland
Other plastic reconstruction of eyelid
+∞
8.3
8
*
WX140
NOMESCO Finland
Parabulbar anesthesy
2.6
8.2
45
175
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
33.6
8.1
10
*
A11CC02
ATC
dihydrotachysterol; oral
11.8
8.1
14
12
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
22.2
8.0
11
5
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
7.8
276
1997
S01EE01
ATC
latanoprost; ophthalmic
2.3
7.7
55
242
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
7.7
136
828
Z71.8
ICD-10 Finland
Other specified counselling
1.5
7.7
339
2567
N02BE01
ATC
paracetamol; systemic, rectal
1.8
7.7
869
7983
Z01.7
ICD-10 Finland
Laboratory examination
1.7
7.7
170
1102
S01ED01
ATC
timolol; ophthalmic
3.2
7.6
30
97
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
25.2
7.6
10
*
E83.51
ICD-10 Finland
Hypocalcemia
7.2
7.5
17
24
H05.0
ICD-10 Finland
Acute inflammation of orbit
80.7
7.4
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
7.4
119
705
R53
ICD-10 Finland
Malaise and fatigue
1.5
7.4
241
1711
ZXC95
NOMESCO Finland
Use of surgical navigator
4.1
7.4
20
50
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
7.3
7
*
H05.1
ICD-10 Finland
Chronic inflammatory disorders of orbit
+∞
7.3
7
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
7.2
409
3246
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
20.2
7.1
10
5
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
20.2
7.1
10
5
E06.3
ICD-10 Finland
Autoimmune thyroiditis
6.4
7.0
17
27
ZX050
NOMESCO Finland
Stereotactic radiotherapy
7.6
6.9
15
20
A02BC05
ATC
esomeprazole; systemic
1.4
6.9
385
3037
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.0
6.8
70
359
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.3
6.7
25
78
107
Kela drug reimbursment
Pernicious anaemia
3.6
6.6
21
59
R03BB04
ATC
tiotropium bromide; inhalant
1.9
6.6
84
463
R4110
NOMESCO Finland
Physiotherapy
1.5
6.6
251
1836
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.4
6.6
23
69
ZXD20
NOMESCO Finland
Day surgery
1.7
6.6
123
761
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
8.8
6.6
13
15
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.3
6.6
49
221
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
3.0
6.5
28
96
H02AB04
ATC
methylprednisolone; systemic
1.7
6.5
133
844
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.3
6.5
24
75
XCW12
NOMESCO Finland
Assessment of colour vision
70.3
6.4
7
*
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
70.3
6.4
7
*
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
70.3
6.4
7
*
K90.0
ICD-10 Finland
Coeliac disease
2.6
6.4
35
136
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
6.4
293
2221
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.4
685
6042
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.4
121
752
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
6.6
6.3
15
23
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
6.3
86
484
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
6.3
97
567
H02.9
ICD-10 Finland
Disorder of eyelid, unspecified
18.1
6.3
9
5
CBN99
NOMESCO Finland
Other operation on eyelid for malposition
+∞
6.3
6
*
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
6.3
6
*
H060, E050,
ICD-10 Finland
+∞
6.3
6
*
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
6.3
6
*
H01CB02
ATC
octreotide; parenteral
12.6
6.1
10
8
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
12.6
6.1
10
8
A04
ICPC
Weakness/tiredness general
1.6
6.1
141
922
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
530
266
42.31
307.65
5.7
1.9
6.06
4.10
iu/l
2.05
379
109
510
604
16.56
307.65
8.5
3.4
4.63
4.53
pmol/l
0.62
486
539
243
748
3.99
69.18
1.5
1.2
201.82
151.31
u/ml
1.10
116
301
957
7209
16.25
62.56
17.0
4.7
15.89
14.68
pmol/l
40.95
929
6694
667
4394
2.63
43.01
7.9
6.5
1.21
1.22
mmol/l
1.56
587
3790
599
3928
2.35
36.23
6.7
5.7
1.21
1.22
mmol/l
1.38
572
3615
180
696
2.94
33.75
2.9
3.5
53.36
80.03
ng/l
9.69
162
622
709
5116
2.40
32.68
10.0
9.3
3.86
3.98
e9/l
0.80
617
4479
959
8261
9.28
30.02
18.8
5.7
1.64
1.87
mu/l
4.13
933
7704
489
3108
2.15
29.78
3.3
3.4
2.33
2.36
mmol/l
5.17
442
2830
608
4280
2.11
27.36
3.0
2.5
76.67
78.51
nmol/l
0.91
569
3902
827
6764
2.44
22.98
9.5
7.7
76.66
78.23
u/l
0.46
807
6412
176
864
2.26
19.40
2.5
2.0
373.18
383.08
nmol/l
0.29
165
810
797
6592
2.13
18.74
5.2
4.2
11.49
11.91
mm/h
0.39
760
6163
639
5017
1.79
16.16
4.7
4.4
6.40
6.57
mmol/l
1.38
613
4738
508
3803
1.70
14.59
4.3
4.6
36.00
36.06
g/l
0.09
476
3605
522
3969
1.68
13.87
11.8
10.5
0.00
0.00
e9/l
0.38
410
3271
295
1930
1.76
13.65
1.6
1.5
2.20
2.37
g/l
0.87
176
1194
37
99
3.85
12.37
4.2
5.4
37.37
46.81
u/ml
0.19
13
33
902
8189
2.31
11.45
6.8
6.0
38.74
38.84
mmol/mol
0.14
863
7700
321
2245
1.64
11.17
1.4
1.3
1.24
1.92
u/ml
0.73
83
602
942
8753
3.07
10.86
19.5
16.0
139.79
139.72
mmol/l
0.41
931
8583
943
8771
3.10
10.77
19.8
16.2
3.92
3.95
mmol/l
2.42
930
8582
25
55
4.64
10.76
1.1
1.1
1.13
0.27
nmol/l
—
7
8
58
226
2.67
10.47
1.2
1.2
55.10
48.59
u/ml
—
6
26
926
8579
2.49
9.87
16.2
13.9
22.01
21.64
mg/l
0.13
770
6968
482
3819
1.52
9.24
2.3
2.1
102.47
97.66
pmol/l
1.26
247
1930
905
8362
2.10
8.76
5.7
5.0
5.84
5.85
mmol/l
0.07
867
7728
315
2310
1.54
8.50
3.1
2.9
0.26
0.39
e6/l
1.02
217
1657
211
1421
1.62
8.20
3.2
3.0
0.82
0.82
mmol/l
0.03
195
1351
51
211
2.50
8.19
2.2
3.2
1.73
2.22
index
0.28
26
110
193
1274
1.64
8.12
3.0
2.9
4.11
3.30
e6/l
0.31
90
567
78
392
2.08
7.94
1.8
1.9
7.89
7.73
iu/ml
0.01
17
94
243
1722
1.55
7.53
2.8
2.8
2.43
2.45
mmol/l
2.45
212
1546
901
8380
1.95
7.50
16.4
13.6
83.69
82.55
ml/min/173m2
1.03
835
7722
220
1533
1.56
7.32
4.4
3.5
205.16
332.52
ng/l
0.37
166
1094
692
6050
1.49
7.30
3.7
3.2
36.00
44.01
u/l
3.16
670
5715
955
9112
3.04
7.12
16.2
11.5
23.79
25.05
u/l
2.28
944
8871
204
1406
1.57
7.11
2.9
2.8
1.63
1.19
e6/l
0.37
102
698
59
279
2.19
7.03
1.3
1.3
2.04
6.63
u/ml
—
5
45
562
4751
1.43
6.86
3.6
3.7
0.04
0.02
estimate
0.21
107
935
117
709
1.74
6.74
2.3
2.8
10.21
10.61
g/l
0.43
108
667
556
4707
1.42
6.63
3.6
3.7
0.00
4.82
estimate
1.07
111
995
551
4659
1.42
6.60
3.6
3.7
0.00
0.00
estimate
0.50
109
969
166
1108
1.60
6.60
4.6
4.9
1.07
1.04
mmol/l
0.61
150
1025
954
9128
2.84
6.49
22.3
18.2
71.05
71.75
umol/l
0.41
945
9021
344
2684
1.43
6.44
3.2
3.1
34.93
49.85
e6/l
0.46
246
2015
287
2166
1.46
6.41
4.3
3.6
92.70
94.90
%
0.82
282
2113
71
375
1.96
6.33
2.1
2.2
42.68
41.39
u/l
0.21
64
339
236
1741
1.47
5.86
1.4
1.3
7.32
10.80
u/ml
0.42
74
699
290
2229
1.43
5.78
2.7
2.2
2.47
2.86
mg/l
3.00
259
1917
20
60
3.38
5.74
6.4
7.2
6.96
25.29
ug/l
1.04
14
38
89
525
1.76
5.64
2.8
2.7
149.11
165.17
ng/l
0.20
79
485
127
826
1.62
5.60
2.2
2.3
29.30
41.14
u/l
2.75
105
697
248
1871
1.44
5.43
1.4
1.3
27.42
29.04
iu/ml
0.07
74
592
40
181
2.26
5.35
2.3
2.3
4.82
4.89
mmol/24h
0.05
34
161
147
1000
1.55
5.35
2.1
2.5
6.05
7.25
umol/l
0.79
123
881
795
7304
1.47
5.22
24.9
17.6
13.58
13.58
%
0.00
789
7215
53
281
1.94
4.73
1.5
1.5
0.23
0.06
iu/ml
—
8
42
533
4641
1.33
4.52
5.9
6.1
11.12
10.90
umol/l
0.14
515
4434
12
23
5.27
4.46
1.6
1.3
0.43
0.38
ug/l
—
7
17
270
2141
1.36
4.28
2.2
2.2
—
—
—
0
0
306
2479
1.34
4.21
1.6
1.7
20.87
20.82
nmol/l
0.02
267
2078
509
4430
1.31
4.21
3.9
3.0
92.04
104.51
ug/l
1.16
482
4167
961
9363
2.52
3.74
30.2
22.0
262.22
258.86
e9/l
0.98
944
9199
961
9366
2.50
3.68
30.0
21.9
91.03
90.98
fl
0.12
955
9278
961
9367
2.49
3.66
30.6
22.2
40.58
40.11
%
2.84
955
9276
961
9367
2.49
3.66
30.1
21.9
4.50
4.46
e12/l
2.56
942
9172
445
3853
1.28
3.64
2.0
1.9
1.27
1.35
mmol/l
1.62
385
3268
961
9370
2.47
3.60
30.3
22.1
135.08
133.86
g/l
2.47
956
9280
23
98
2.38
3.59
1.3
1.2
—
—
—
0
0
51
297
1.76
3.46
1.1
2.1
0.63
1.19
g/l
0.37
46
265
473
4147
1.27
3.43
2.6
2.6
—
—
estimate
—
0
0
618
5601
1.28
3.40
3.1
3.1
—
—
—
0
0
172
1317
1.37
3.35
1.7
1.7
1081.82
1214.32
nmol/l
1.27
126
986
100
695
1.49
3.32
3.2
3.4
1.22
1.23
mmol/l
1.03
93
588
230
1844
1.32
3.30
2.4
2.5
6.33
7.26
e6/l
0.39
199
1679
88
597
1.52
3.28
1.6
1.9
—
—
—
0
0
15
55
2.75
3.16
2.3
2.0
—
—
—
0
0
54
330
1.67
3.11
1.5
1.7
—
—
—
0
0
315
2657
1.27
3.05
2.3
2.0
151.92
188.06
u/l
0.47
292
2533
157
1204
1.36
3.02
2.2
2.3
157.15
111.79
ug/g
0.40
127
957
360
3096
1.26
2.95
3.4
3.0
28.46
30.48
u/l
0.81
343
2943
182
1437
1.33
2.89
2.6
2.4
14.51
13.30
umol/l
1.40
172
1337
52
323
1.64
2.84
1.1
2.0
3.02
2.95
g/l
0.18
47
301
69
459
1.54
2.84
1.5
1.7
—
—
—
0
0
23
110
2.12
2.80
1.2
1.4
—
—
—
0
0
15
59
2.57
2.79
1.1
1.3
38.95
28.29
umol/l
0.42
15
53
167
1312
1.33
2.74
2.5
2.4
2.44
2.36
g/l
0.93
156
1215
168
1325
1.32
2.69
2.0
1.8
—
—
—
0
0
47
289
1.66
2.68
1.1
2.0
9.63
10.54
g/l
1.11
42
265
419
3696
1.23
2.66
11.5
11.7
1.19
1.18
inr
0.25
358
3044
127
963
1.37
2.64
1.9
1.7
—
—
—
0
0
244
2028
1.27
2.62
1.9
1.7
1.01
1.08
mg/l
0.14
186
1565
81
571
1.46
2.55
1.4
1.4
26.23
30.06
iu/l
0.51
65
499
26
136
1.94
2.52
1.7
1.6
—
—
—
0
0
19
88
2.18
2.52
1.6
1.3
0.44
0.69
u/ml
0.16
11
43
80
565
1.45
2.49
1.3
1.3
71.52
43.40
au/ml
—
6
43
39
233
1.70
2.49
1.2
1.1
—
—
—
0
0
70
483
1.48
2.46
1.0
1.0
—
—
—
0
0
39
234
1.69
2.45
1.1
1.1
—
—
—
0
0
119
905
1.36
2.43
3.1
4.3
230.35
250.85
u/l
0.72
110
867
22
412
0.52
2.41
4.5
3.6
56.86
48.08
%
0.76
22
401
93
684
1.40
2.34
1.6
2.9
66.38
67.33
g/l
0.61
84
636
25
133
1.90
2.33
1.0
1.1
2.23
2.25
eliau/ml
—
7
54
17
78
2.20
2.32
1.1
1.1
—
—
—
0
0
52
342
1.55
2.29
1.1
2.0
4.25
4.35
g/l
0.44
47
320
52
342
1.55
2.29
1.1
2.0
7.74
7.45
g/l
0.66
47
320
52
342
1.55
2.29
1.1
2.0
4.12
3.74
g/l
0.33
47
320
16
73
2.21
2.22
1.1
1.2
—
—
—
0
0
28
158
1.79
2.19
1.0
1.1
0.58
1.34
u/ml
0.63
16
74
69
487
1.45
2.19
1.4
1.7
—
—
—
0
0
16
74
2.18
2.15
1.1
1.1
—
—
—
0
0
893
8650
1.37
2.09
5.2
5.1
4.79
4.79
mmol/l
0.02
843
8120
5
10
5.02
2.07
2.0
1.9
—
—
—
0
0
42
271
1.57
2.03
1.3
1.4
275.41
299.76
ug/g
0.33
27
157
16
76
2.12
2.03
1.1
1.1
—
—
—
0
0
16
76
2.12
2.03
1.1
1.1
—
—
—
0
0
17
83
2.07
2.02
1.5
1.6
—
—
—
0
0
205
1721
1.24
2.00
1.6
1.5
—
—
—
0
0
25
141
1.79
1.98
1.2
1.2
1.77
3.37
u/ml
0.47
13
43
13
57
2.30
1.98
1.5
1.5
46.46
111.38
ng/l
3.87
13
57
24
134
1.81
1.96
1.2
1.4
—
—
—
0
0
24
134
1.81
1.96
1.2
1.4
—
—
—
0
0
24
134
1.81
1.96
1.0
1.1
0.42
4.18
u/ml
1.96
14
53
18
91
2.00
1.96
1.3
1.2
—
—
—
0
0
6
16
3.77
1.93
1.0
1.2
—
—
—
0
0
43
283
1.54
1.93
1.6
1.6
0.23
0.23
g/l
0.16
38
272
82
615
1.36
1.87
2.5
2.4
15.35
21.93
au/ml
—
6
69
41
269
1.55
1.87
1.3
1.2
—
—
—
0
0
148
1206
1.27
1.87
2.7
2.4
23.05
22.67
%
0.14
137
1128
40
262
1.55
1.84
2.5
1.9
159.49
232.13
ug/l
0.57
35
244
901
8762
1.36
1.84
6.1
5.7
2.83
2.80
mmol/l
0.35
849
8187
18
94
1.93
1.81
1.5
1.6
—
—
—
0
0
39
256
1.55
1.78
1.9
3.7
33.44
44.27
mg/l
0.99
30
227
9
36
2.51
1.74
1.3
2.3
67.89
51.03
ug/l
—
9
36
226
1951
1.21
1.67
1.4
1.5
—
—
—
0
0
10
40
2.52
1.67
2.0
3.1
0.90
0.85
index
—
10
40
43
294
1.48
1.65
1.6
1.6
1.17
1.19
g/l
0.15
38
280
331
2960
1.18
1.65
3.1
3.3
6.97
7.23
mmol/l
0.46
288
2520
110
880
1.28
1.63
7.9
7.2
1.19
1.05
mmol/l
0.15
89
740
886
8617
1.30
1.62
5.1
5.0
1.52
1.53
mmol/l
0.41
832
8033
58
781
0.73
1.58
1.8
1.7
3.50
3.49
mmol/l
0.02
42
558
114
920
1.27
1.58
2.0
1.8
—
—
—
0
0
38
256
1.50
1.57
1.9
3.7
31.70
57.43
mg/l
1.00
29
227
27
168
1.62
1.56
1.5
1.6
—
—
—
0
0
73
555
1.34
1.56
1.5
1.6
—
—
—
0
0
268
2365
1.18
1.55
2.7
3.0
1271.22
986.30
ng/l
0.49
226
1990
290
2581
1.18
1.51
3.3
3.1
0.01
0.01
estimate
0.05
94
785
11
51
2.17
1.51
1.2
1.1
—
—
—
0
0
46
326
1.43
1.49
1.7
1.7
1.39
1.47
g/l
0.25
36
287
19
314
0.60
1.43
1.4
1.8
—
—
—
0
0
60
453
1.35
1.37
1.2
1.5
—
—
—
0
0
6
23
2.62
1.37
2.3
1.3
—
—
—
0
0
34
232
1.48
1.35
1.4
3.4
1.11
3.64
ratio
0.96
17
134
14
76
1.85
1.30
2.7
3.5
—
—
—
0
0
308
2785
1.15
1.29
2.8
2.4
53.42
59.77
u/l
1.40
292
2587
82
654
1.28
1.28
1.9
1.5
—
—
—
0
0
48
356
1.37
1.24
1.6
1.6
14.29
10.08
u/ml
—
8
80
22
139
1.60
1.24
1.3
1.2
2.63
4.96
u/ml
0.56
16
51
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
29
197
1.49
1.20
1.0
1.1
0.58
2.18
u/ml
1.59
16
101
20
126
1.60
1.15
1.9
2.8
—
2437.25
—
0
12
11
58
1.91
1.12
1.3
1.5
—
18.67
—
0
9
85
1033
0.81
1.12
1.8
2.0
3.21
3.36
ratio
0.66
68
810
10
52
1.93
1.06
1.0
1.2
—
—
—
0
0
15
90
1.68
1.04
1.1
1.2
—
—
—
0
0
80
655
1.24
1.04
2.9
3.0
0.72
0.76
ug/l
0.26
52
399
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
344
3176
1.13
1.03
3.0
3.4
75.79
61.96
ng/l
0.10
199
2125
11
60
1.84
1.03
1.1
1.5
9.80
10.44
umol/l
0.13
11
55
35
257
1.38
1.00
1.4
1.6
67.27
59.76
ug/l
0.26
27
212
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
10
54
1.86
0.97
1.5
1.3
15.90
9.43
mm/h
—
10
54
32
233
1.39
0.96
3.1
2.6
—
—
—
0
0
12
198
0.60
0.96
1.3
1.6
—
—
—
0
0
305
2809
1.12
0.95
3.9
4.0
4.29
7.53
mg/mmol
1.65
169
1663
7
37
1.90
0.94
1.6
1.6
—
—
—
0
0
239
2170
1.13
0.93
2.5
2.5
313.05
324.94
umol/l
1.08
216
1934
6
28
2.15
0.91
1.0
1.2
—
—
—
0
0
5
102
0.49
0.89
1.0
1.1
—
—
—
0
0
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
28
204
1.38
0.86
1.3
1.2
15.85
12.21
u/l
0.48
22
164
22
154
1.44
0.84
1.2
1.4
177.14
162.20
au/ml
—
7
42
18
121
1.50
0.83
1.1
1.0
0.16
0.39
u/ml
—
7
39
40
311
1.30
0.82
1.8
1.7
258.43
294.69
mu/l
0.52
35
281
10
58
1.73
0.80
1.1
1.1
—
—
—
0
0
33
251
1.33
0.79
1.2
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
2.6
—
10.85
—
0
24
0
24
0.00
0.79
0.0
2.6
—
4.68
—
0
24
28
208
1.36
0.78
1.9
1.6
2745.90
13722.30
e6/l
2.35
21
151
111
972
1.16
0.75
2.0
2.0
—
—
—
0
0
11
171
0.64
0.72
1.3
1.7
—
—
—
0
0
9
57
1.58
0.71
5.7
3.5
75.78
119.35
nmol/l
—
9
57
16
109
1.48
0.71
1.1
1.2
—
—
—
0
0
17
118
1.45
0.69
1.2
2.2
4.84
6.04
umol/l
0.31
11
84
19
135
1.42
0.69
1.1
1.1
0.25
2.91
—
5
23
29
374
0.77
0.68
1.1
1.2
0.96
0.90
g/l
0.52
29
374
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
31
242
1.29
0.65
1.4
1.5
—
—
—
0
0
31
243
1.28
0.63
1.4
1.5
1.12
0.98
ratio
0.71
14
157
31
243
1.28
0.63
1.4
1.5
0.99
1.10
ratio
0.29
14
157
31
243
1.28
0.63
1.4
1.5
1.18
1.20
ratio
0.04
14
157
31
243
1.28
0.63
1.1
1.1
3.23
4.36
—
7
32
100
883
1.15
0.62
1.9
1.9
—
—
—
0
0
8
49
1.64
0.62
1.1
1.1
1446.00
1641.53
miu/ml
—
8
49
134
1208
1.13
0.61
3.1
1.9
30.11
29.27
s
0.48
128
1174
5
30
1.67
0.61
1.2
1.1
47.24
34.39
u/ml
—
5
30
16
113
1.42
0.61
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
200
1.31
0.61
4.5
2.8
0.31
0.36
iu/ml
0.29
11
111
28
218
1.29
0.60
1.6
1.5
—
—
—
0
0
36
290
1.25
0.60
1.4
1.5
—
—
—
0
0
87
763
1.15
0.60
3.1
3.3
2.11
1.83
mmol/l
0.30
65
663
27
343
0.78
0.59
1.1
1.1
0.54
0.65
ratio
—
5
37
29
365
0.79
0.59
1.1
1.2
1.63
1.59
g/l
0.42
29
365
60
699
0.85
0.58
2.4
2.4
70.00
68.60
ml/min/173m2
0.11
27
295
10
65
1.54
0.55
1.6
1.5
—
—
—
0
0
6
37
1.63
0.55
1.5
1.7
—
—
—
0
0
6
37
1.63
0.55
1.5
1.7
—
—
—
0
0
6
37
1.63
0.55
1.5
1.7
—
—
—
0
0
6
37
1.63
0.55
1.5
1.7
—
—
—
0
0
38
312
1.23
0.55
1.7
1.9
—
—
—
0
0
33
267
1.24
0.54
1.3
1.3
—
—
—
0
0
26
204
1.28
0.54
1.7
1.5
—
—
—
0
0
6
38
1.58
0.54
1.5
2.3
—
—
—
0
0
9
60
1.50
0.54
1.1
1.2
—
—
—
0
0
9
61
1.48
0.53
1.1
1.2
—
—
—
0
0
15
108
1.39
0.53
1.1
1.2
—
—
—
0
0
9
63
1.43
0.52
2.4
1.5
—
—
—
0
0
10
146
0.68
0.52
1.1
1.5
94.77
55.28
ug/l
—
10
146
98
878
1.13
0.51
3.8
4.3
21.59
22.35
%
0.23
40
413
39
324
1.21
0.51
1.1
1.3
193.21
233.14
miu/ml
0.30
20
158
20
153
1.31
0.50
1.2
1.3
—
—
—
0
0
35
422
0.82
0.50
1.7
1.5
—
—
—
0
0
29
234
1.25
0.50
5.7
2.1
178.72
182.20
%
0.08
29
227
372
3559
1.07
0.49
3.6
3.6
0.31
0.06
estimate
0.42
91
792
88
973
0.89
0.43
6.7
6.3
—
—
—
0
0
34
285
1.20
0.43
1.6
1.8
—
—
—
0
0
5
31
1.62
0.43
5.0
5.2
—
—
—
0
0
19
149
1.28
0.42
1.6
1.4
—
—
—
0
0
8
59
1.36
0.41
2.5
2.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
15
194
0.77
0.40
1.1
1.6
—
—
—
0
0
836
8255
1.09
0.40
4.3
4.2
1.23
1.26
mmol/l
1.01
776
7634
43
372
1.16
0.39
1.3
1.6
0.21
0.37
mg/l
1.98
18
163
5
35
1.43
0.39
2.2
1.8
97.60
106.77
%
—
5
35
24
197
1.22
0.38
2.0
2.0
133.83
129.77
g/l
0.37
18
158
192
1812
1.07
0.37
1.7
1.7
73054310.48
38951252.66
pmol/l
0.28
167
1525
12
158
0.76
0.37
2.4
1.8
51.42
44.41
nmol/l
0.23
12
151
25
298
0.83
0.35
1.1
1.4
73.20
236.47
pmol/l
1.93
25
291
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
14
178
0.78
0.34
1.3
1.7
0.74
0.82
nmol/l
—
9
150
51
454
1.13
0.33
1.3
1.5
—
—
—
0
0
19
230
0.82
0.31
1.1
1.3
—
—
—
0
0
20
166
1.21
0.30
3.2
4.0
158.77
2176.69
u/ml
0.74
20
157
30
260
1.16
0.29
1.1
1.4
—
—
—
0
0
78
845
0.92
0.29
2.9
4.4
221.36
20.23
ug/l
0.46
63
678
88
816
1.09
0.28
2.4
2.1
0.21
0.21
g/l
0.14
79
767
47
423
1.12
0.27
1.4
1.6
1149.77
1002.28
mu/l
0.29
37
344
13
104
1.25
0.26
2.2
1.4
—
—
—
0
0
118
1112
1.07
0.26
5.3
5.0
2.39
2.26
ug/l
0.09
107
994
211
2028
1.05
0.25
3.4
3.9
1.02
1.75
kg/l
0.50
147
1381
9
75
1.20
0.25
1.2
1.0
—
—
—
0
0
109
1027
1.07
0.25
1.4
1.8
1.41
1.40
%
0.02
95
910
9
77
1.17
0.24
1.7
1.5
—
—
—
0
0
9
77
1.17
0.24
1.7
1.5
—
—
—
0
0
9
77
1.17
0.24
1.7
1.5
—
—
—
0
0
19
161
1.18
0.24
1.3
1.4
—
—
—
0
0
23
199
1.16
0.23
2.5
4.3
15.78
33.38
u/ml
1.93
23
194
5
38
1.32
0.23
1.0
2.0
43.76
41.31
g/l
—
5
38
5
38
1.32
0.23
1.4
2.2
—
447.80
—
0
5
33
367
0.90
0.21
1.6
1.8
3.17
4.64
mg/l
0.41
24
267
85
799
1.07
0.21
3.1
3.3
5.74
5.80
kpa
0.22
76
776
21
182
1.16
0.21
1.6
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
8.86
—
0
10
29
258
1.13
0.21
4.0
1.9
96.72
94.87
%
0.19
29
248
0
12
0.00
0.21
0.0
1.0
—
10.28
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.8
—
1.25
—
0
8
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
19
164
1.16
0.20
1.1
1.1
11.00
16.46
au/ml
—
5
43
9
115
0.78
0.20
1.0
1.1
—
1.15
—
0
5
9
115
0.78
0.20
1.8
2.0
160.33
199.27
pmol/l
—
9
109
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
25
223
1.12
0.18
1.4
1.4
—
—
—
0
0
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
7
61
1.15
0.17
1.0
1.3
1.17
1.26
promille
—
7
47
5
70
0.71
0.16
1.0
1.4
—
—
—
0
0
58
614
0.94
0.14
2.1
2.4
6.08
6.53
ug/l
0.09
48
549
12
104
1.16
0.12
2.6
2.0
32.42
31.98
pg
0.15
12
104
71
680
1.05
0.11
7.1
6.4
8.48
8.88
mmol/l
0.23
63
657
16
143
1.12
0.11
1.9
1.6
—
—
—
0
0
16
178
0.90
0.11
1.9
2.3
10.75
129.73
ug/min
2.15
11
102
13
115
1.13
0.10
1.0
1.3
—
—
—
0
0
19
173
1.10
0.10
1.8
1.3
—
—
—
0
0
11
125
0.88
0.10
1.0
1.1
—
—
—
0
0
33
351
0.94
0.10
2.8
3.3
25.16
25.51
mmol/l
0.27
27
338
25
232
1.08
0.10
1.6
1.5
—
—
—
0
0
10
87
1.15
0.09
1.2
1.1
103.40
110.99
pmol/l
—
10
87
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
5
61
0.82
0.08
1.6
1.0
—
—
—
0
0
5
60
0.83
0.08
1.4
1.3
71.60
76.95
umol/l
—
5
60
7
67
1.05
0.08
3.3
2.5
—
—
—
0
0
13
118
1.10
0.07
1.0
1.3
—
—
—
0
0
14
128
1.10
0.06
1.3
1.5
—
—
—
0
0
42
437
0.96
0.06
1.4
1.5
—
—
—
0
0
13
119
1.09
0.06
1.0
1.3
—
—
—
0
0
65
668
0.97
0.06
2.9
2.8
4.79
4.52
kpa
0.55
60
650
84
821
1.03
0.05
2.9
3.0
—
—
—
0
0
15
140
1.07
0.04
1.1
1.1
—
—
—
0
0
51
497
1.03
0.04
3.1
2.9
133.00
129.35
g/l
0.55
45
479
109
1075
1.02
0.03
5.4
4.9
33.40
32.61
%
0.28
73
721
35
341
1.03
0.02
1.5
2.1
483.54
4788.08
u/l
2.45
13
141
20
208
0.96
0.02
1.4
1.6
538.50
506.26
e6/l
0.02
14
160
260
2588
1.01
0.02
3.7
3.9
0.00
0.00
estimate
1.08
109
930
13
124
1.05
0.00
2.2
1.8
—
—
—
0
0
11
114
0.96
0.00
1.0
1.4
—
—
—
0
0
12
122
0.98
0.00
3.8
3.8
1.02
0.80
nmol/l
0.86
12
101
16
162
0.99
0.00
1.2
1.2
264.10
236.46
u/ml
—
10
94
10
97
1.03
0.00
1.2
1.1
—
—
—
0
0
11
113
0.97
0.00
1.0
1.4
—
—
—
0
0
11
113
0.97
0.00
1.0
1.4
—
—
—
0
0
15
149
1.01
0.00
1.3
1.2
18.08
19.54
u/l
0.08
15
126
111
1113
1.00
0.00
7.5
6.1
104.38
104.18
mmol/l
0.18
111
1113
44
445
0.99
0.00
3.2
3.2
1.91
1.83
mmol/l
0.05
34
334
20
205
0.98
0.00
1.4
1.5
10.62
17.33
e6/l
0.29
13
154
8
86
0.93
0.00
1.4
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.01
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
9
95
0.95
-0.00
2.1
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.03
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.01
—
0
9
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
49
1.02
-0.00
1.2
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: H7_LACRIMALORBITINOTH – Disorders of lacrimal system and orbit in diseases classified elsewhere
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).